Africa Israel, bondholders reach deal

Africa Israel, bondholde

October 30, 2009 08:40


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

At the end of marathon talks overnight Thursday, Africa Israel Investments Ltd. came to an agreement with bondholders to settle the debts of the beleaguered company owned by diamond mogul Lev Leviev. According to the deal signed in the wee hours of Friday morning, the holding and investment company will issue shares in order to raise NIS 850 million, from which Leviev will transfer NIS 750 million in order to cover the firm's debts to creditors. The company was valued at NIS 2 billion for the sake of the settlement. Leviev will retain control of the firm, but his stake will drop to 52 percent. The remainder of the company's debts will be settled by means of spreading out loan repayments and converting bonds to shares. The deal is pending the approval of the banks to which Africa Israel owes money. The company has lost some $1.4 billion since the beginning of 2008, battered in large part by soured real-estate investments in the US and Russia. The company's debt currently totals some $5.5 billion. AP contributed to this report

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection